OCUL vs PRU · rev $24.3M vs rev $31.19B
Ocular Therapeutix Inc (OCUL) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
PRU (PRU) common stock.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
OCUL currently screens at market cap $1.76B. PRU currently screens at market cap $0.
Not investment advice. Open the OCUL and PRU stock pages for the full models.
Not investment advice.